deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT05638620

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID (DSBLongCOVID)

Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)

Sponsor: Jonathann Kuo, MD

Conditions COVID-19 Recurrent Dysautonomia Dysautonomia Like Disorder Dysautonomia Orthostatic Hypotension Syndrome Long COVID Long Covid19 Post Acute COVID-19 Syndrome Post Acute Sequelae of COVID-19 Post COVID-19 Condition Post COVID-19 Condition, Unspecified Post-Acute COVID-19 Post-Acute COVID-19 Infection Post-COVID Syndrome Post-COVID-19 Syndrome SARS-CoV2 Infection
Interventions stellate ganglion block with 0.5% bupivacaine
Updated 7 times since 2023 Last updated: Mar 10, 2025 Started: Jan 3, 2023 Primary completion: Jun 15, 2023 Completion: Dec 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates COVID-19 Recurrent and Dysautonomia and is currently completed. Jonathann Kuo, MD leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshotRecruiting~Feb 2023 – ~Jul 2023 · 5 months · monthly snapshotRecruiting~Jul 2023 – ~Oct 2023 · 3 months · monthly snapshotActive Not Recruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotActive Not Recruiting~Apr 2025 – present · 17 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Apr 2025 — Present [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  2. Sep 2024 — Apr 2025 [monthly]

    Active Not Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

  4. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

  5. Jul 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

  1. Feb 2023 — Jul 2023 [monthly]

    Recruiting PHASE1

  2. Jan 2023 — Feb 2023 [monthly]

    Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jonathann Kuo, MD
Data source: Hudson Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations